SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.
| Revenue (TTM) | $175.17M |
| Gross Profit (TTM) | $125.86M |
| EBITDA | $68.63M |
| Operating Margin | 38.60% |
| Return on Equity | 18.90% |
| Return on Assets | 11.30% |
| Revenue/Share (TTM) | $1.71 |
| Book Value | $2.49 |
| Price-to-Book | 1.42 |
| Price-to-Sales (TTM) | 2.14 |
| EV/Revenue | 1.359 |
| EV/EBITDA | 3.01 |
| Quarterly Earnings Growth (YoY) | 338.90% |
| Quarterly Revenue Growth (YoY) | 13.40% |
| Shares Outstanding | $102.85M |
| Float | $18.11M |
| % Insiders | 81.53% |
| % Institutions | 4.40% |
Volatility is currently expanding
SBC Medical Group NASDAQ: SBC said its second-quarter 2026 results reflected a reacceleration in growth following structural reforms undertaken in 2025, with adjusted EBITDA rising faster than revenue despite the effect of a weaker yen on reported results.
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.
IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced it will release its financial results for the second quarter ended June 30, 2026, before U.S. market open on August 13, 2026.
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that Stephen Rodgers, Head of Global Planning and Strategy, and Hikaru Fukui, Head of IR Department, have been invited to present at “Health, Wellness & Longevity,” presented by Maxim Group LLC, on Wednesday, July 22nd at 10:30 a.m.
IRVINE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced the opening of SBC MEN'S FLASH CLINIC Ikebukuro, a clinic dedicated exclusively to men's beard hair removal, in Tokyo on August 6, 2026.
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in May and June 2026.
Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026 Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2026 / Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgrading the Company to a Buy rating and increasing its 12-month price target to $10.00 from $9.00, representing significant potential upside from the Company's recent share price of $2.89 as of May 19, 2026. The Quarterly Update highlights SBC's expectation for a return to revenue growth in 2026 following the completion of pricing-related headwinds experienced during 2025, while emphasizing the Company's strong cash position, expanding clinic footprint, and long-term global growth strategy.
SBC Medical Group NASDAQ: SBC reported first-quarter 2026 revenue of $43 million, down 9% from a year earlier, as management said prior fee structure revisions continued to weigh on reported results even as underlying clinic activity improved.
IRVINE, Calif.--(BUSINESS WIRE)-- #1Q--SBC Medical announce to first quarter financial results.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SBC and any ticker you trade — then tracks every position and per-strategy win rate.
